Schizophrenia Trial, Recruiting (NCT06958341)

Schizophrenia Trial, Recruiting NCT06958341 Sponsor: Charite University, Berlin, Germany Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06958341 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are suspected of having a neuroimmunological disease (a condition where the immune system affects the nervous system) and for whom a spinal fluid test (lumbar puncture) has already been recommended as part of their diagnosis and treatment planning
People whose diagnosis is unclear and where extra spinal fluid (an additional 2–3 ml) can safely be collected during the procedure to allow researchers to study certain immune cells and produce specific proteins for research purposes
People of any age
People of any gender

Who may not be able to join:

People who withdraw their consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Nikolaus, MD, Charite - Universitaetsmedizin Berlin

Phone: +49 30 450 566112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06958341

Sponsor: Charite University, Berlin, Germany

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +49 30 450 566112

More information: https://clinicaltrials.gov/study/NCT06958341

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are suspected of having a neuroimmunological disease (a condition where the immune system affects the nervous system) and for whom a spinal fluid test (lumbar puncture) has already been recommended as part of their diagnosis and treatment planning
People whose diagnosis is unclear and where extra spinal fluid (an additional 2–3 ml) can safely be collected during the procedure to allow researchers to study certain immune cells and produce specific proteins for research purposes
People of any age
People of any gender

Who may not be able to join:

People who withdraw their consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

1 February 2021

Est. completion

1 January 2031

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Screening for a panel of anti-neuronal antibodies via commercial assays; Screening for unknown anti-neuronal antibodies via immunofluorescence staining on fresh mouse brain (tissue-based assay, TBA); Determination of the molecular weight of the antibody target; CSF cell count; CSF protein; CSF albumin; CSF glucose; CSF lactate; CSF IgG; CSF oligoclonal bands

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov